HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.

Abstract
Immunohistochemical expression of napsin A in primary pulmonary mucinous tumors is not well established. Napsin A immunoreactivity was evaluated in 43 mucin-producing adenocarcinomas of the lung consisting of 18 tumors formerly classified as mucinous bronchioloalveolar carcinoma, 15 colloid adenocarcinomas, 5 solid predominant adenocarcinomas with mucin production, and 5 adenocarcinomas with signet ring cell features, as well as in 25 extrapulmonary mucinous adenocarcinomas of different anatomic sites. Immunohistochemical expression of thyroid transcription factor 1 (TTF-1) was also compared. Thirty-three percent of mucinous lung tumors exhibited positive immunoreactivity for napsin A, whereas 42% expressed TTF-1. All 25 extrapulmonary mucinous adenocarcinomas lacked expression of napsin A and TTF-1. Mucin-producing neoplasms of the lung infrequently express napsin A, suggesting that immunohistochemical assessment of napsin A may have limited diagnostic usefulness for distinguishing primary and metastatic mucinous adenocarcinomas involving the lung.
AuthorsJeffrey Wu, Peiguo G Chu, Zhong Jiang, Sean K Lau
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 139 Issue 2 Pg. 160-6 (Feb 2013) ISSN: 1943-7722 [Electronic] England
PMID23355200 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • TTF1 protein, human
  • Transcription Factors
  • Aspartic Acid Endopeptidases
  • NAPSA protein, human
Topics
  • Adenocarcinoma (metabolism, pathology, surgery)
  • Aspartic Acid Endopeptidases (metabolism)
  • Biomarkers, Tumor (metabolism)
  • DNA-Binding Proteins (metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (metabolism, pathology, surgery)
  • Transcription Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: